GeoVax Labs (GOVX) Current Assets (2010 - 2026)
GeoVax Labs (GOVX) posted quarterly Current Assets of $4.2 million for Q2 2026, down 18.7% year-over-year from $5.1 million in Q2 2025, and down 21.44% quarter-over-quarter from $5.3 million in Q4 2025.
GeoVax Labs (GOVX) Current Assets (2010 - 2026) Analysis & Trends
GeoVax Labs (GOVX) has reported Current Assets for 17 consecutive years, with $4.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Assets fell 18.7% year-over-year to $4.2 million; the TTM figure through Jun 2026 stood at $4.2 million (down 18.7% YoY), while the FY2025 annual figure was $5.3 million, down 33.02% from the prior year.
- Current Assets eased to $4.2 million in Q2 2026 per GOVX's latest filing, from $5.3 million in the prior quarter.
- Across five years, Current Assets topped out at $36.1 million in Q3 2022 and bottomed at $2.9 million in Q1 2024.
- Historically, Current Assets has averaged $14.1 million across 5 years, with a median of $10.6 million in 2025.
- Annual changes were most pronounced in 2024 — Current Assets sank 88.99% — and 2025, when it surged 270.75%.
- GeoVax Labs' Current Assets stood at $28.9 million in 2022, then plunged by 72.75% to $7.9 million in 2023, then grew by 0.62% to $7.9 million in 2024, then sank by 33.02% to $5.3 million in 2025, then declined by 21.44% to $4.2 million in 2026.
- Business Quant data shows GOVX's Current Assets at $4.2 million in Q2 2026, $5.3 million in Q4 2025, and $6.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 1.76 Bn |
| 10 | GeoVax Labs | 2.93 Mn | -209,363.39 | - | 4.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.18 Mn |
| Dec 31, 2025 | 5.31 Mn |
| Sep 30, 2025 | 6.52 Mn |
| Jun 30, 2025 | 5.14 Mn |
| Mar 31, 2025 | 10.61 Mn |
| Dec 31, 2024 | 7.93 Mn |
| Sep 30, 2024 | 10.87 Mn |
| Jun 30, 2024 | 3.84 Mn |
| Mar 31, 2024 | 2.86 Mn |
| Dec 31, 2023 | 7.89 Mn |
| Sep 30, 2023 | 14.80 Mn |
| Jun 30, 2023 | 19.83 Mn |
| Mar 31, 2023 | 25.99 Mn |
| Dec 31, 2022 | 28.94 Mn |
| Sep 30, 2022 | 36.14 Mn |
| Jun 30, 2022 | 32.04 Mn |
| Mar 31, 2022 | 16.64 Mn |
| Dec 31, 2021 | 11.63 Mn |
| Sep 30, 2021 | 18.16 Mn |
| Jun 30, 2021 | 19.66 Mn |